Related Experiment Video
Updated: Jul 7, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Mutant B-RAF mediates resistance to anoikis via Bad and Bim
1Center for Cell Biology and Cancer Research, Albany Medical College, Albany, NY 12208, USA.
Abstract:
Normal cells undergo anoikis when they lose adhesion to or encounter an inappropriate extracellular matrix. By contrast, oncogenic signaling in tumor cells enables resistance to anoikis, a trait that contributes to tumor progression. The B-RAF serine-threonine kinase is mutated in multiple cancers and functions as an oncogene in melanoma. Previously, we demonstrated that B-RAF and downstream mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) signaling are necessary for protection from anoikis in mutant B-RAF-expressing melanoma cells. Regulation of Bcl-2 family members in melanoma and their role in B-RAF-mediated survival is poorly defined. Here, we provide evidence that B-RAF-MEK signaling protects against anoikis through alterations in two proapoptotic Bcl-2 family proteins: Bcl-xL/Bcl-2-associated death promoter (Bad) and Bcl-2-interacting mediator of cell death (Bim). B-RAF-MEK signaling regulates phosphorylation of the inhibitory serine-75 residue of Bad, and decreases Bad mRNA expression. RNA interference and overexpression experiments demonstrate that Bad contributes to the susceptibility of B-RAF-depleted cells to anoikis. Additionally, B-RAF-MEK signaling regulates the expression of Bim(EL), mainly through control of protein turnover. Increased Bim(EL) levels induce apoptosis in suspended cells and are required for anoikis in B-RAF-depleted cells. Depletion of Bim together with Bad has an additive effect on protecting B-RAF knockdown cells from anoikis. Together, our data show that Bad and Bim are major B-RAF responsive proteins regulating apoptosis in melanoma cells.
Insights
Melanoma cells resist anoikis, a form of programmed cell death, through B-RAF-MEK signaling. This pathway impacts Bad and Bim proteins, crucial regulators of apoptosis in cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Research
Background:
- Anoikis is programmed cell death triggered by loss of cell-matrix adhesion, a process tumor cells often evade.
- Mutant B-RAF oncogene signaling is critical for melanoma progression and survival.
- The role of Bcl-2 family proteins in B-RAF-mediated melanoma survival and anoikis resistance is not well understood.
Purpose of the Study:
- To investigate the mechanisms by which B-RAF-MEK signaling confers anoikis resistance in melanoma.
- To identify key Bcl-2 family proteins regulated by B-RAF-MEK signaling that control anoikis.
Main Methods:
- Utilized RNA interference and overexpression experiments in melanoma cells.
- Analyzed B-RAF-MEK signaling effects on phosphorylation and mRNA/protein expression of Bad and Bim.
- Assessed the role of Bad and Bim in anoikis susceptibility upon B-RAF depletion.
Main Results:
- B-RAF-MEK signaling protects against anoikis by modulating the proapoptotic proteins Bad and Bim.
- B-RAF-MEK signaling decreases Bad mRNA expression and regulates its phosphorylation.
- B-RAF-MEK signaling controls Bim(EL) protein turnover, with increased Bim(EL) inducing apoptosis in suspended cells.
Conclusions:
- Bad and Bim are key B-RAF-responsive proteins that regulate apoptosis and anoikis in melanoma.
- Targeting Bad and Bim pathways could offer therapeutic strategies for melanoma treatment.
- Understanding these mechanisms is vital for developing novel cancer therapies.
More Related Videos
06:44Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
The Ras Gene
Ras is a superfamily...
Abnormal Proliferation